Global Wet Macular Degeneration Supply, Demand and Key Producers, 2023-2029

Page: 118

Published Date: 01 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Wet Macular Degeneration market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Wet macular degeneration is a chronic eye disorder that induces vague vision or a blind spot in the patient's visual field.

This report studies the global Wet Macular Degeneration demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Wet Macular Degeneration, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Wet Macular Degeneration that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Wet Macular Degeneration total market, 2018-2029, (USD Million)
Global Wet Macular Degeneration total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Wet Macular Degeneration total market, key domestic companies and share, (USD Million)
Global Wet Macular Degeneration revenue by player and market share 2018-2023, (USD Million)
Global Wet Macular Degeneration total market by Type, CAGR, 2018-2029, (USD Million)
Global Wet Macular Degeneration total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Wet Macular Degeneration market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals, Inc., Novartis AG, Bausch Health Companies Inc., Apellis Pharmaceuticals Inc., GlaxoSmithKline plc, Ophthotech Corporation and Gilead Sciences, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Wet Macular Degeneration market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Wet Macular Degeneration Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Wet Macular Degeneration Market, Segmentation by Type
by Drug
Lucentis
Eylea
Avastin
Others
by Route of Administration
Intravitreal
Intravenous

Global Wet Macular Degeneration Market, Segmentation by Application
Hospitals
Clinics
Research Institutes
Academic Institutes

Companies Profiled:
Pfizer Inc.
F. Hoffmann-La Roche AG
Regeneron Pharmaceuticals, Inc.
Novartis AG
Bausch Health Companies Inc.
Apellis Pharmaceuticals Inc.
GlaxoSmithKline plc
Ophthotech Corporation
Gilead Sciences, Inc.
Alcon
Genzyme Corporation
Boehringer Ingelheim GmbH
EyeGate Pharmaceuticals, Inc.
EyeCyte, Inc.
PanOptica Inc

Key Questions Answered
1. How big is the global Wet Macular Degeneration market?
2. What is the demand of the global Wet Macular Degeneration market?
3. What is the year over year growth of the global Wet Macular Degeneration market?
4. What is the total value of the global Wet Macular Degeneration market?
5. Who are the major players in the global Wet Macular Degeneration market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Wet Macular Degeneration Introduction
    1.2 World Wet Macular Degeneration Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Wet Macular Degeneration Total Market by Region (by Headquarter Location)
        1.3.1 World Wet Macular Degeneration Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Wet Macular Degeneration Market Size (2018-2029)
        1.3.3 China Wet Macular Degeneration Market Size (2018-2029)
        1.3.4 Europe Wet Macular Degeneration Market Size (2018-2029)
        1.3.5 Japan Wet Macular Degeneration Market Size (2018-2029)
        1.3.6 South Korea Wet Macular Degeneration Market Size (2018-2029)
        1.3.7 ASEAN Wet Macular Degeneration Market Size (2018-2029)
        1.3.8 India Wet Macular Degeneration Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Wet Macular Degeneration Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Wet Macular Degeneration Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Wet Macular Degeneration Consumption Value (2018-2029)
    2.2 World Wet Macular Degeneration Consumption Value by Region
        2.2.1 World Wet Macular Degeneration Consumption Value by Region (2018-2023)
        2.2.2 World Wet Macular Degeneration Consumption Value Forecast by Region (2024-2029)
    2.3 United States Wet Macular Degeneration Consumption Value (2018-2029)
    2.4 China Wet Macular Degeneration Consumption Value (2018-2029)
    2.5 Europe Wet Macular Degeneration Consumption Value (2018-2029)
    2.6 Japan Wet Macular Degeneration Consumption Value (2018-2029)
    2.7 South Korea Wet Macular Degeneration Consumption Value (2018-2029)
    2.8 ASEAN Wet Macular Degeneration Consumption Value (2018-2029)
    2.9 India Wet Macular Degeneration Consumption Value (2018-2029)

3 World Wet Macular Degeneration Companies Competitive Analysis
    3.1 World Wet Macular Degeneration Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Wet Macular Degeneration Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Wet Macular Degeneration in 2022
        3.2.3 Global Concentration Ratios (CR8) for Wet Macular Degeneration in 2022
    3.3 Wet Macular Degeneration Company Evaluation Quadrant
    3.4 Wet Macular Degeneration Market: Overall Company Footprint Analysis
        3.4.1 Wet Macular Degeneration Market: Region Footprint
        3.4.2 Wet Macular Degeneration Market: Company Product Type Footprint
        3.4.3 Wet Macular Degeneration Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Wet Macular Degeneration Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Wet Macular Degeneration Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Wet Macular Degeneration Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Wet Macular Degeneration Consumption Value Comparison
        4.2.1 United States VS China: Wet Macular Degeneration Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Wet Macular Degeneration Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Wet Macular Degeneration Companies and Market Share, 2018-2023
        4.3.1 United States Based Wet Macular Degeneration Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Wet Macular Degeneration Revenue, (2018-2023)
    4.4 China Based Companies Wet Macular Degeneration Revenue and Market Share, 2018-2023
        4.4.1 China Based Wet Macular Degeneration Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Wet Macular Degeneration Revenue, (2018-2023)
    4.5 Rest of World Based Wet Macular Degeneration Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Wet Macular Degeneration Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Wet Macular Degeneration Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Wet Macular Degeneration Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Lucentis
        5.2.2 Eylea
        5.2.3 Avastin
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Wet Macular Degeneration Market Size by Type (2018-2023)
        5.3.2 World Wet Macular Degeneration Market Size by Type (2024-2029)
        5.3.3 World Wet Macular Degeneration Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Wet Macular Degeneration Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Clinics
        6.2.3 Research Institutes
        6.2.4 Academic Institutes
        6.2.5 Academic Institutes
    6.3 Market Segment by Application
        6.3.1 World Wet Macular Degeneration Market Size by Application (2018-2023)
        6.3.2 World Wet Macular Degeneration Market Size by Application (2024-2029)
        6.3.3 World Wet Macular Degeneration Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Pfizer Inc.
        7.1.1 Pfizer Inc. Details
        7.1.2 Pfizer Inc. Major Business
        7.1.3 Pfizer Inc. Wet Macular Degeneration Product and Services
        7.1.4 Pfizer Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Pfizer Inc. Recent Developments/Updates
        7.1.6 Pfizer Inc. Competitive Strengths & Weaknesses
    7.2 F. Hoffmann-La Roche AG
        7.2.1 F. Hoffmann-La Roche AG Details
        7.2.2 F. Hoffmann-La Roche AG Major Business
        7.2.3 F. Hoffmann-La Roche AG Wet Macular Degeneration Product and Services
        7.2.4 F. Hoffmann-La Roche AG Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 F. Hoffmann-La Roche AG Recent Developments/Updates
        7.2.6 F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
    7.3 Regeneron Pharmaceuticals, Inc.
        7.3.1 Regeneron Pharmaceuticals, Inc. Details
        7.3.2 Regeneron Pharmaceuticals, Inc. Major Business
        7.3.3 Regeneron Pharmaceuticals, Inc. Wet Macular Degeneration Product and Services
        7.3.4 Regeneron Pharmaceuticals, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
        7.3.6 Regeneron Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    7.4 Novartis AG
        7.4.1 Novartis AG Details
        7.4.2 Novartis AG Major Business
        7.4.3 Novartis AG Wet Macular Degeneration Product and Services
        7.4.4 Novartis AG Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Novartis AG Recent Developments/Updates
        7.4.6 Novartis AG Competitive Strengths & Weaknesses
    7.5 Bausch Health Companies Inc.
        7.5.1 Bausch Health Companies Inc. Details
        7.5.2 Bausch Health Companies Inc. Major Business
        7.5.3 Bausch Health Companies Inc. Wet Macular Degeneration Product and Services
        7.5.4 Bausch Health Companies Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Bausch Health Companies Inc. Recent Developments/Updates
        7.5.6 Bausch Health Companies Inc. Competitive Strengths & Weaknesses
    7.6 Apellis Pharmaceuticals Inc.
        7.6.1 Apellis Pharmaceuticals Inc. Details
        7.6.2 Apellis Pharmaceuticals Inc. Major Business
        7.6.3 Apellis Pharmaceuticals Inc. Wet Macular Degeneration Product and Services
        7.6.4 Apellis Pharmaceuticals Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Apellis Pharmaceuticals Inc. Recent Developments/Updates
        7.6.6 Apellis Pharmaceuticals Inc. Competitive Strengths & Weaknesses
    7.7 GlaxoSmithKline plc
        7.7.1 GlaxoSmithKline plc Details
        7.7.2 GlaxoSmithKline plc Major Business
        7.7.3 GlaxoSmithKline plc Wet Macular Degeneration Product and Services
        7.7.4 GlaxoSmithKline plc Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 GlaxoSmithKline plc Recent Developments/Updates
        7.7.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
    7.8 Ophthotech Corporation
        7.8.1 Ophthotech Corporation Details
        7.8.2 Ophthotech Corporation Major Business
        7.8.3 Ophthotech Corporation Wet Macular Degeneration Product and Services
        7.8.4 Ophthotech Corporation Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Ophthotech Corporation Recent Developments/Updates
        7.8.6 Ophthotech Corporation Competitive Strengths & Weaknesses
    7.9 Gilead Sciences, Inc.
        7.9.1 Gilead Sciences, Inc. Details
        7.9.2 Gilead Sciences, Inc. Major Business
        7.9.3 Gilead Sciences, Inc. Wet Macular Degeneration Product and Services
        7.9.4 Gilead Sciences, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Gilead Sciences, Inc. Recent Developments/Updates
        7.9.6 Gilead Sciences, Inc. Competitive Strengths & Weaknesses
    7.10 Alcon
        7.10.1 Alcon Details
        7.10.2 Alcon Major Business
        7.10.3 Alcon Wet Macular Degeneration Product and Services
        7.10.4 Alcon Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Alcon Recent Developments/Updates
        7.10.6 Alcon Competitive Strengths & Weaknesses
    7.11 Genzyme Corporation
        7.11.1 Genzyme Corporation Details
        7.11.2 Genzyme Corporation Major Business
        7.11.3 Genzyme Corporation Wet Macular Degeneration Product and Services
        7.11.4 Genzyme Corporation Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Genzyme Corporation Recent Developments/Updates
        7.11.6 Genzyme Corporation Competitive Strengths & Weaknesses
    7.12 Boehringer Ingelheim GmbH
        7.12.1 Boehringer Ingelheim GmbH Details
        7.12.2 Boehringer Ingelheim GmbH Major Business
        7.12.3 Boehringer Ingelheim GmbH Wet Macular Degeneration Product and Services
        7.12.4 Boehringer Ingelheim GmbH Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Boehringer Ingelheim GmbH Recent Developments/Updates
        7.12.6 Boehringer Ingelheim GmbH Competitive Strengths & Weaknesses
    7.13 EyeGate Pharmaceuticals, Inc.
        7.13.1 EyeGate Pharmaceuticals, Inc. Details
        7.13.2 EyeGate Pharmaceuticals, Inc. Major Business
        7.13.3 EyeGate Pharmaceuticals, Inc. Wet Macular Degeneration Product and Services
        7.13.4 EyeGate Pharmaceuticals, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 EyeGate Pharmaceuticals, Inc. Recent Developments/Updates
        7.13.6 EyeGate Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    7.14 EyeCyte, Inc.
        7.14.1 EyeCyte, Inc. Details
        7.14.2 EyeCyte, Inc. Major Business
        7.14.3 EyeCyte, Inc. Wet Macular Degeneration Product and Services
        7.14.4 EyeCyte, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 EyeCyte, Inc. Recent Developments/Updates
        7.14.6 EyeCyte, Inc. Competitive Strengths & Weaknesses
    7.15 PanOptica Inc
        7.15.1 PanOptica Inc Details
        7.15.2 PanOptica Inc Major Business
        7.15.3 PanOptica Inc Wet Macular Degeneration Product and Services
        7.15.4 PanOptica Inc Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 PanOptica Inc Recent Developments/Updates
        7.15.6 PanOptica Inc Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Wet Macular Degeneration Industry Chain
    8.2 Wet Macular Degeneration Upstream Analysis
    8.3 Wet Macular Degeneration Midstream Analysis
    8.4 Wet Macular Degeneration Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Wet Macular Degeneration Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Wet Macular Degeneration Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Wet Macular Degeneration Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Wet Macular Degeneration Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Wet Macular Degeneration Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Wet Macular Degeneration Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Wet Macular Degeneration Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Wet Macular Degeneration Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Wet Macular Degeneration Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Wet Macular Degeneration Players in 2022
    Table 12. World Wet Macular Degeneration Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Wet Macular Degeneration Company Evaluation Quadrant
    Table 14. Head Office of Key Wet Macular Degeneration Player
    Table 15. Wet Macular Degeneration Market: Company Product Type Footprint
    Table 16. Wet Macular Degeneration Market: Company Product Application Footprint
    Table 17. Wet Macular Degeneration Mergers & Acquisitions Activity
    Table 18. United States VS China Wet Macular Degeneration Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Wet Macular Degeneration Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Wet Macular Degeneration Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Wet Macular Degeneration Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Wet Macular Degeneration Revenue Market Share (2018-2023)
    Table 23. China Based Wet Macular Degeneration Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Wet Macular Degeneration Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Wet Macular Degeneration Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Wet Macular Degeneration Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Wet Macular Degeneration Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Wet Macular Degeneration Revenue Market Share (2018-2023)
    Table 29. World Wet Macular Degeneration Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Wet Macular Degeneration Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Wet Macular Degeneration Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Wet Macular Degeneration Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Wet Macular Degeneration Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Wet Macular Degeneration Market Size by Application (2024-2029) & (USD Million)
    Table 35. Pfizer Inc. Basic Information, Area Served and Competitors
    Table 36. Pfizer Inc. Major Business
    Table 37. Pfizer Inc. Wet Macular Degeneration Product and Services
    Table 38. Pfizer Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Pfizer Inc. Recent Developments/Updates
    Table 40. Pfizer Inc. Competitive Strengths & Weaknesses
    Table 41. F. Hoffmann-La Roche AG Basic Information, Area Served and Competitors
    Table 42. F. Hoffmann-La Roche AG Major Business
    Table 43. F. Hoffmann-La Roche AG Wet Macular Degeneration Product and Services
    Table 44. F. Hoffmann-La Roche AG Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. F. Hoffmann-La Roche AG Recent Developments/Updates
    Table 46. F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
    Table 47. Regeneron Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
    Table 48. Regeneron Pharmaceuticals, Inc. Major Business
    Table 49. Regeneron Pharmaceuticals, Inc. Wet Macular Degeneration Product and Services
    Table 50. Regeneron Pharmaceuticals, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
    Table 52. Regeneron Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    Table 53. Novartis AG Basic Information, Area Served and Competitors
    Table 54. Novartis AG Major Business
    Table 55. Novartis AG Wet Macular Degeneration Product and Services
    Table 56. Novartis AG Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Novartis AG Recent Developments/Updates
    Table 58. Novartis AG Competitive Strengths & Weaknesses
    Table 59. Bausch Health Companies Inc. Basic Information, Area Served and Competitors
    Table 60. Bausch Health Companies Inc. Major Business
    Table 61. Bausch Health Companies Inc. Wet Macular Degeneration Product and Services
    Table 62. Bausch Health Companies Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Bausch Health Companies Inc. Recent Developments/Updates
    Table 64. Bausch Health Companies Inc. Competitive Strengths & Weaknesses
    Table 65. Apellis Pharmaceuticals Inc. Basic Information, Area Served and Competitors
    Table 66. Apellis Pharmaceuticals Inc. Major Business
    Table 67. Apellis Pharmaceuticals Inc. Wet Macular Degeneration Product and Services
    Table 68. Apellis Pharmaceuticals Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Apellis Pharmaceuticals Inc. Recent Developments/Updates
    Table 70. Apellis Pharmaceuticals Inc. Competitive Strengths & Weaknesses
    Table 71. GlaxoSmithKline plc Basic Information, Area Served and Competitors
    Table 72. GlaxoSmithKline plc Major Business
    Table 73. GlaxoSmithKline plc Wet Macular Degeneration Product and Services
    Table 74. GlaxoSmithKline plc Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. GlaxoSmithKline plc Recent Developments/Updates
    Table 76. GlaxoSmithKline plc Competitive Strengths & Weaknesses
    Table 77. Ophthotech Corporation Basic Information, Area Served and Competitors
    Table 78. Ophthotech Corporation Major Business
    Table 79. Ophthotech Corporation Wet Macular Degeneration Product and Services
    Table 80. Ophthotech Corporation Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Ophthotech Corporation Recent Developments/Updates
    Table 82. Ophthotech Corporation Competitive Strengths & Weaknesses
    Table 83. Gilead Sciences, Inc. Basic Information, Area Served and Competitors
    Table 84. Gilead Sciences, Inc. Major Business
    Table 85. Gilead Sciences, Inc. Wet Macular Degeneration Product and Services
    Table 86. Gilead Sciences, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Gilead Sciences, Inc. Recent Developments/Updates
    Table 88. Gilead Sciences, Inc. Competitive Strengths & Weaknesses
    Table 89. Alcon Basic Information, Area Served and Competitors
    Table 90. Alcon Major Business
    Table 91. Alcon Wet Macular Degeneration Product and Services
    Table 92. Alcon Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Alcon Recent Developments/Updates
    Table 94. Alcon Competitive Strengths & Weaknesses
    Table 95. Genzyme Corporation Basic Information, Area Served and Competitors
    Table 96. Genzyme Corporation Major Business
    Table 97. Genzyme Corporation Wet Macular Degeneration Product and Services
    Table 98. Genzyme Corporation Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Genzyme Corporation Recent Developments/Updates
    Table 100. Genzyme Corporation Competitive Strengths & Weaknesses
    Table 101. Boehringer Ingelheim GmbH Basic Information, Area Served and Competitors
    Table 102. Boehringer Ingelheim GmbH Major Business
    Table 103. Boehringer Ingelheim GmbH Wet Macular Degeneration Product and Services
    Table 104. Boehringer Ingelheim GmbH Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Boehringer Ingelheim GmbH Recent Developments/Updates
    Table 106. Boehringer Ingelheim GmbH Competitive Strengths & Weaknesses
    Table 107. EyeGate Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
    Table 108. EyeGate Pharmaceuticals, Inc. Major Business
    Table 109. EyeGate Pharmaceuticals, Inc. Wet Macular Degeneration Product and Services
    Table 110. EyeGate Pharmaceuticals, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. EyeGate Pharmaceuticals, Inc. Recent Developments/Updates
    Table 112. EyeGate Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    Table 113. EyeCyte, Inc. Basic Information, Area Served and Competitors
    Table 114. EyeCyte, Inc. Major Business
    Table 115. EyeCyte, Inc. Wet Macular Degeneration Product and Services
    Table 116. EyeCyte, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. EyeCyte, Inc. Recent Developments/Updates
    Table 118. PanOptica Inc Basic Information, Area Served and Competitors
    Table 119. PanOptica Inc Major Business
    Table 120. PanOptica Inc Wet Macular Degeneration Product and Services
    Table 121. PanOptica Inc Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 122. Global Key Players of Wet Macular Degeneration Upstream (Raw Materials)
    Table 123. Wet Macular Degeneration Typical Customers
List of Figure
    Figure 1. Wet Macular Degeneration Picture
    Figure 2. World Wet Macular Degeneration Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Wet Macular Degeneration Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Wet Macular Degeneration Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Wet Macular Degeneration Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Wet Macular Degeneration Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Wet Macular Degeneration Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Wet Macular Degeneration Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Wet Macular Degeneration Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Wet Macular Degeneration Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Wet Macular Degeneration Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Wet Macular Degeneration Revenue (2018-2029) & (USD Million)
    Figure 13. Wet Macular Degeneration Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Wet Macular Degeneration Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Wet Macular Degeneration by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Wet Macular Degeneration Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Wet Macular Degeneration Markets in 2022
    Figure 27. United States VS China: Wet Macular Degeneration Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Wet Macular Degeneration Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Wet Macular Degeneration Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Wet Macular Degeneration Market Size Market Share by Type in 2022
    Figure 31. Lucentis
    Figure 32. Eylea
    Figure 33. Avastin
    Figure 34. Others
    Figure 35. World Wet Macular Degeneration Market Size Market Share by Type (2018-2029)
    Figure 36. World Wet Macular Degeneration Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Wet Macular Degeneration Market Size Market Share by Application in 2022
    Figure 38. Hospitals
    Figure 39. Clinics
    Figure 40. Research Institutes
    Figure 41. Academic Institutes
    Figure 42. Wet Macular Degeneration Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer Inc.
F. Hoffmann-La Roche AG
Regeneron Pharmaceuticals, Inc.
Novartis AG
Bausch Health Companies Inc.
Apellis Pharmaceuticals Inc.
GlaxoSmithKline plc
Ophthotech Corporation
Gilead Sciences, Inc.
Alcon
Genzyme Corporation
Boehringer Ingelheim GmbH
EyeGate Pharmaceuticals, Inc.
EyeCyte, Inc.
PanOptica Inc

Related Reports

Global Wet Macular Degeneration Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Wet Macular Degeneration Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 29 Jan 2021

date Pharma & Healthcare

The Wet Macular Degeneration market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Wet Macular Degeneration Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Wet Macular Degeneration Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 15 Jan 2022

date Pharma & Healthcare

Global Wet Macular Degeneration Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Wet Macular Degeneration Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 01 Jan 2023

date Pharma & Healthcare

Wet macular degeneration is a chronic eye disorder that induces vague vision or a blind spot in the patient's visual field.

Global Wet Macular Degeneration Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Wet Macular Degeneration Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Wet Macular Degeneration market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

wet macular degeneration

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>